tlooto
Sign up

Evaluation of the anti-tumor activity of histone deacetylase inhibitors (HDAC6) on human pancreatic adenocarcinoma (PANC-1) cell line using a zebrafish xenograft model

Mays Helmi

2024.9.1Precision Cancer Medicine

DOI: 10.21037/pcm-23-8

Abstract

Abstract is not available.

Citation format

HELMI, Mays. Evaluation of the anti-tumor activity of histone deacetylase inhibitors (HDAC6) on human pancreatic adenocarcinoma (PANC-1) cell line using a zebrafish xenograft model. Precision Cancer Medicine, 2024.